Position in A
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,326,440
+$84,856 QoQ
Shares Held
9,986
-8.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#454
of 1,112 holders
Holding Since
Mar 2021
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Derivatives in A
reported options exposure · as of Mar 31, 2021CallValue
$8,009,820
CallShares
63,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SANDLER CAPITAL MANAGEMENT holds $6,353,594 across 4 Diagnostics & Research names. A ranks #3 (20.9% of the industry book) .
All Filings in A
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,326,440 | 9,986 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,241,584 | 10,893 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,464,635 | 18,113 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,770,948 | 21,589 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,869,042 | 15,838 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $2,108,416 | 14,200 | Shares | Sole | 2024-11-14 | |
| 2023-03-31 | $3,328,875 | 24,063 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,341,780 | 109,200 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $9,592,601 | 72,490 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $7,117,677 | 45,183 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $28,894,342 | 195,483 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,009,820 | 63,000 | Call | Sole | 2021-05-17 | |
| 2021-03-31 | $21,972,334 | 172,820 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||